Provided by Tiger Trade Technology Pte. Ltd.

TherapeuticsMD

2.08
+0.02000.97%
Volume:9K
Turnover:18.39K
Market Cap:24.07M
PE:-110.94
High:2.09
Open:2.06
Low:2.06
Close:2.06
52wk High:2.95
52wk Low:0.9900
Shares:11.57M
Float Shares:9.49M
Volume Ratio:0.39
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0187
EPS(LYR):-0.0527
ROE:-1.08%
ROA:-2.88%
PB:0.89
PE(LYR):-39.44

Loading ...

Aug 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2026

Major Issues Report

Form 8-K - Current report
Aug 05, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2026

Major Issues Report

Form 8-K - Current report
Apr 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 01, 2026

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 31, 2026

Major Issues Report

Form 8-K - Current report
Mar 30, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 21, 2026

Major Issues Report

Form 8-K - Current report
Dec 16, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 09, 2025

Major Issues Report

Form 8-K - Current report
Mar 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]